The BCL2 -938C>A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty

• Patrick Stelmach ,

  Contributed equally to this work with: Patrick Stelmach, Christian Wedemeyer

  Affiliation Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany

  ⨯
• Christian Wedemeyer ,

  Contributed equally to this work with: Patrick Stelmach, Christian Wedemeyer

  Affiliation Department of Orthopaedics and Trauma Surgery, University Hospital Essen, Essen, Germany

  ⨯
• Lena Fuest,

  Affiliations Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany, Department of Orthopaedics and Trauma Surgery, University Hospital Essen, Essen, Germany

  ⨯
• Gina Kurscheid,

  Affiliations Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany, Department of Orthopaedics and Trauma Surgery, University Hospital Essen, Essen, Germany

  ⨯
• Thorsten Gehrke,

  Affiliation Department of Joint Surgery, Helios ENDO-Klinik, Hamburg, Germany

  ⨯
• Stefanie Klenke,

  Affiliations Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany, Department of Anaesthesiology and Intensive Care, University Hospital Essen, Essen, Germany

  ⨯
• Marcus Jäger,

  Affiliation Department of Orthopaedics and Trauma Surgery, University Hospital Essen, Essen, Germany

  ⨯
• Max D. Kauther,

  Affiliation Department of Orthopaedics and Trauma Surgery, University Hospital Essen, Essen, Germany

  ⨯
• Hagen S. Bachmann

  * E-mail: hagen.bachmann@uk-essen.de

  Affiliation Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany

  ⨯